InspireMD (NSPR) Competitors $2.41 +0.07 (+2.99%) Closing price 04:00 PM EasternExtended Trading$2.41 0.00 (0.00%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NSPR vs. DRTS, NYXH, XAIR, SMTI, STIM, ZIMV, SKIN, TCMD, BWAY, and NVROShould you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Alpha Tau Medical (DRTS), Nyxoah (NYXH), Beyond Air (XAIR), Sanara MedTech (SMTI), Neuronetics (STIM), ZimVie (ZIMV), Beauty Health (SKIN), Tactile Systems Technology (TCMD), Brainsway (BWAY), and Nevro (NVRO). These companies are all part of the "medical equipment" industry. InspireMD vs. Its Competitors Alpha Tau Medical Nyxoah Beyond Air Sanara MedTech Neuronetics ZimVie Beauty Health Tactile Systems Technology Brainsway Nevro InspireMD (NYSE:NSPR) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings. Do institutionals & insiders hold more shares of NSPR or DRTS? 44.8% of InspireMD shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 34.1% of InspireMD shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, NSPR or DRTS? InspireMD has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Is NSPR or DRTS more profitable? Alpha Tau Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Alpha Tau Medical's return on equity of -49.48% beat InspireMD's return on equity.Company Net Margins Return on Equity Return on Assets InspireMD-413.96% -69.42% -57.68% Alpha Tau Medical N/A -49.48%-36.69% Does the media refer more to NSPR or DRTS? In the previous week, Alpha Tau Medical's average media sentiment score of 1.87 beat InspireMD's score of 0.44 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment InspireMD Neutral Alpha Tau Medical Very Positive Do analysts rate NSPR or DRTS? InspireMD presently has a consensus price target of $4.50, suggesting a potential upside of 86.72%. Alpha Tau Medical has a consensus price target of $8.00, suggesting a potential upside of 161.44%. Given Alpha Tau Medical's higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than InspireMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, NSPR or DRTS? InspireMD has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspireMD$7.03M10.51-$19.92M-$0.79-3.05Alpha Tau MedicalN/AN/A-$31.75M-$0.46-6.65 SummaryAlpha Tau Medical beats InspireMD on 8 of the 11 factors compared between the two stocks. Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSPR vs. The Competition Export to ExcelMetricInspireMDSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$73.83M$69.11M$5.50B$20.79BDividend YieldN/AN/A4.25%3.67%P/E Ratio-3.215.2628.1027.50Price / Sales10.51207.52380.1585.29Price / CashN/A18.4135.5321.88Price / Book1.327.518.264.66Net Income-$19.92M-$25.04M$3.24B$994.58M7 Day Performance-0.82%7.28%0.50%-0.69%1 Month PerformanceN/A3.13%7.99%5.41%1 Year Performance-0.82%42.03%28.68%9.18% InspireMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPRInspireMD2.8195 of 5 stars$2.41+3.0%$4.50+86.7%-4.1%$73.83M$7.03M-3.2150DRTSAlpha Tau Medical3.157 of 5 stars$3.23+5.6%$8.00+147.7%+43.5%$273.97MN/A-7.0280Positive NewsHigh Trading VolumeNYXHNyxoah2.5397 of 5 stars$7.84+3.7%$14.50+84.9%-15.2%$267.03M$4.36M-3.68110Positive NewsXAIRBeyond Air4.6087 of 5 stars$3.05-11.6%$1.50-50.8%-72.0%$263.43M$3.70M-3.8670Analyst ForecastHigh Trading VolumeSMTISanara MedTech2.137 of 5 stars$28.87-0.7%$49.50+71.5%-12.4%$256.65M$86.67M-21.5460Positive NewsHigh Trading VolumeSTIMNeuronetics1.7902 of 5 stars$3.86+8.1%$5.50+42.5%+80.0%$255.19M$74.89M-2.95180ZIMVZimVie2.3429 of 5 stars$8.93-0.8%$16.33+82.9%-54.4%$248.67M$443.55M-12.581,770News CoveragePositive NewsSKINBeauty Health0.2716 of 5 stars$1.87-2.1%$1.42-24.2%-21.8%$235.61M$322.47M-4.561,030TCMDTactile Systems Technology3.7436 of 5 stars$10.04+0.8%$16.00+59.4%-23.2%$233.43M$292.98M15.211,037Positive NewsBWAYBrainsway2.6886 of 5 stars$12.23-0.6%$14.25+16.5%+81.9%$231.15M$41.02M61.15120Positive NewsNVRONevroN/A$5.85+0.1%$5.36-8.3%-42.1%$224.32M$408.52M-3.091,090 Related Companies and Tools Related Companies DRTS Competitors NYXH Competitors XAIR Competitors SMTI Competitors STIM Competitors ZIMV Competitors SKIN Competitors TCMD Competitors BWAY Competitors NVRO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSPR) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
